Table 2.
Baseline Clinical Characteristics of Patients Included and Excluded in the Final Analysis
| Included, N=904 | Excluded, N=99 | P value | |
|---|---|---|---|
| Age, y | 69±12 | 73±12 | 0.001 |
| Men (%) | 541 (60) | 60 (61) | 0.88 |
| Hypertension (%) | 590 (65) | 67 (68) | 0.63 |
| Diabetes mellitus (%) | 257 (28) | 27 (27) | 0.81 |
| Hyperlipidemia (%) | 233 (26) | 23 (23) | 0.58 |
| Ever smoker (%) | 275 (30) | 22 (22) | 0.09 |
| Atrial fibrillation (%) | 115 (13) | 15 (15) | 0.49 |
| History of ischemic heart disease (%) | 77 (9) | 15 (15) | 0.030 |
| History of TIA/stroke (%) | 141 (16) | 13 (13) | 0.52 |
| GFR, mL/min per 1.73 m2 | 79±24 | 72±28 | 0.010 |
| Modified Rankin Scale | 2.1±1.5 | 2.5±2.2 | 0.013 |
| TOAST classification | 0.28 | ||
| Small‐vessel disease (%) | 380 (42) | 45 (45) | |
| Large‐artery atherosclerosis (%) | 317 (35) | 25 (25) | |
| Cardioembolic (%) | 106 (12) | 18 (18) | |
| Other/undetermined cause (%) | 101 (11) | 11 (11) |
GFR indicates glomerular filtration rate; TIA, transient ischemic attack; and TOAST, Trial of Org 10172 in Acute Stroke Treatment.